Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL
· Real-Time Price · USD
1.11
-0.11 (-9.02%)
At close: Aug 19, 2025, 12:03 PM
-9.02% (1D)
| Bid | 1.1 |
| Market Cap | 92.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -35.79M |
| EPS (ttm) | -0.35 |
| PE Ratio (ttm) | -3.19 |
| Forward PE | -2.39 |
| Analyst | Buy |
| Ask | 1.13 |
| Volume | 506,199 |
| Avg. Volume (20D) | 588,103 |
| Open | 1.21 |
| Previous Close | 1.22 |
| Day's Range | 1.10 - 1.22 |
| 52-Week Range | 0.77 - 2.63 |
| Beta | 0.79 |
About CRDL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRDL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRDL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+14.75%
Cardiol Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
10 months ago
-6.63%
Cardiol Therapeutics shares are trading lower after the company announced a $13.5 million public offering of 8,437,500 common shares priced at $1.60 per unit.
2 months ago · newsfilecorp.com
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of ShareholdersToronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti...
